{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:44:26Z","timestamp":1784087066805,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF22H040016"],"award-info":[{"award-number":["LGF22H040016"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374113"],"award-info":[{"award-number":["82374113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82205024"],"award-info":[{"award-number":["82205024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KYA25"],"award-info":[{"award-number":["2022KYA25"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3500202"],"award-info":[{"award-number":["2022YFC3500202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3500200"],"award-info":[{"award-number":["2022YFC3500200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021524","name":"School of Life Sciences and Biotechnology Division of Life Sciences, Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jphs.2024.02.015","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T11:43:47Z","timestamp":1709639027000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K\/AKT pathway and the down-regulation of cyclin D1 expression"],"prefix":"10.1016","volume":"155","author":[{"given":"Caijie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jphs.2024.02.015_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jmig.2012.05.009","article-title":"Diagnosis and management of endometrial hyperplasia","volume":"19","author":"Armstrong","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"issue":"6","key":"10.1016\/j.jphs.2024.02.015_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/AOG.0000000000004989","article-title":"Endometrial hyperplasia","volume":"140","author":"Ring","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jphs.2024.02.015_bib3","first-page":"232","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12905-022-02015-2","article-title":"Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database","volume":"22","author":"Park","year":"2022","journal-title":"BMC Wom Health"},{"issue":"5","key":"10.1016\/j.jphs.2024.02.015_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajog.2016.06.006","article-title":"Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women","volume":"215","author":"Wise","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jphs.2024.02.015_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110764","article-title":"Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2024.02.015_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114064","article-title":"Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis","volume":"274","author":"Zhang","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jphs.2024.02.015_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112609","article-title":"Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review","volume":"204","author":"Al Zahrani","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"17","key":"10.1016\/j.jphs.2024.02.015_bib9","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1016\/j.bmc.2008.07.063","article-title":"Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate","volume":"16","author":"Dodo","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jphs.2024.02.015_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.etap.2016.08.019","article-title":"Gallic acid attenuates chromium-induced thyroid dysfunction by modulating antioxidant status and inflammatory cytokines","volume":"48","author":"Mohamed","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.015_bib11","article-title":"Biochemical and electrocardiographic studies on the beneficial effects of gallic acid in cyclophosphamide-induced cardiorenal dysfunction","volume":"14","author":"Ogunsanwo","year":"2017","journal-title":"J Compl Integr Med"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.015_bib12","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.apsb.2022.08.022","article-title":"New opportunities and challenges of natural products research: when target identification meets single-cell multiomics","volume":"12","author":"Zhu","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"10.1016\/j.jphs.2024.02.015_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00394-011-0273-5","article-title":"Protective effects of olive oil phenolics and gallic acid on hydrogen peroxide-induced apoptosis","volume":"51","author":"Erol-Dayi","year":"2012","journal-title":"Eur J Nutr"},{"issue":"7","key":"10.1016\/j.jphs.2024.02.015_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11655-021-3345-2","article-title":"Gallic acid: a potential anti-cancer agent","volume":"28","author":"Jiang","year":"2022","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jphs.2024.02.015_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110985","article-title":"Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases","volume":"133","author":"Bai","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2024.02.015_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.intimp.2019.02.025","article-title":"Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis","volume":"70","author":"Fan","year":"2019","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jphs.2024.02.015_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.intimp.2018.09.048","article-title":"Gallic acid inhibits the expression of keratin 16 and keratin 17 through Nrf2 in psoriasis-like skin disease","volume":"65","author":"Zhang","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jphs.2024.02.015_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.intimp.2018.11.049","article-title":"Gallic acid improved inflammation via NF-kappaB pathway in TNBS-induced ulcerative colitis","volume":"67","author":"Zhu","year":"2019","journal-title":"Int Immunopharm"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10753-015-0258-2","article-title":"Gallic acid-g-Chitosan modulates inflammatory responses in LPS-stimulated RAW264.7 cells via NF-kappaB, AP-1, and MAPK pathways","volume":"39","author":"Ahn","year":"2016","journal-title":"Inflammation"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.015_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/abbs\/gmy115","article-title":"Gallic acid inhibits fibroblast growth and migration in keloids through the AKT\/ERK signaling pathway","volume":"50","author":"Wang","year":"2018","journal-title":"Acta Biochim Biophys Sin"},{"issue":"12","key":"10.1016\/j.jphs.2024.02.015_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17697-1","article-title":"PLK1 inhibition exhibits strong anti-tumoral activity in -driven breast cancer metastases with acquired palbociclib resistance","volume":"11","author":"Montaudon","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.015_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jphs.2020.04.006","article-title":"CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma","volume":"143","author":"Ding","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jphs.2024.02.015_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153575","article-title":"Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT\/CyclinD1\/p21\/p27 pathway","volume":"87","author":"Yang","year":"2021","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.015_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ng.3076","article-title":"Genetic landscape of esophageal squamous cell carcinoma","volume":"46","author":"Gao","year":"2014","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.jphs.2024.02.015_bib26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41401-020-00551-x","article-title":"Suppression of the USP10\/CCND1 axis induces glioblastoma cell apoptosis","volume":"42","author":"Sun","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jphs.2024.02.015_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-8-138","article-title":"CyclinD1, a prominent prognostic marker for endometrial diseases","volume":"8","author":"Liang","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jphs.2024.02.015_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jphs.2024.02.015_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2019.02.002","article-title":"PIK3CA in cancer: the past 30 years","volume":"59","author":"Arafeh","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.jphs.2024.02.015_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.joca.2020.02.027","article-title":"The PI3K\/AKT\/mTOR signaling pathway in osteoarthritis: a narrative review","volume":"28","author":"Sun","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jphs.2024.02.015_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113821","article-title":"Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K\/AKT\/mTOR signaling pathway","volume":"270","author":"Liu","year":"2021","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.jphs.2024.02.015_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/cc.2.4.433","article-title":"Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression","volume":"2","author":"Liang","year":"2003","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","article-title":"Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors","volume":"66","author":"Cai","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"13","key":"10.1016\/j.jphs.2024.02.015_bib34","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","article-title":"Molecular pathways: targeting the cyclin D-CDK4\/6 Axis for cancer treatment","volume":"21","author":"VanArsdale","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jphs.2024.02.015_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154593","article-title":"Paeonol ameliorates endometrial hyperplasia in mice via inhibiting PI3K\/AKT pathway-related ferroptosis","volume":"109","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jphs.2024.02.015_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110399","article-title":"Protective effect of eicosapentaenoic acid against estradiol valerate-induced endometrial hyperplasia via modulation of NF-kappaB\/HIF-1alpha\/VEGF signaling pathway in rats","volume":"373","author":"Abdelzaher","year":"2023","journal-title":"Chem Biol Interact"},{"issue":"15","key":"10.1016\/j.jphs.2024.02.015_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.4103\/0366-6999.211551","article-title":"Effect of high-fat diet-induced disorders on rat with endometrial hyperplasia and adiponectin System in circulation and uterus","volume":"130","author":"Shang","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.jphs.2024.02.015_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.07.008","article-title":"Mechanisms underlying the protective effect of montelukast in prevention of endometrial hyperplasia in female rats","volume":"62","author":"Abdelzaher","year":"2018","journal-title":"Int Immunopharm"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/clinem\/dgz015","article-title":"Mitochondrial dysfunction induced by high estradiol concentrations in endometrial epithelial cells","volume":"105","author":"Chou","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.015_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7030060","article-title":"A classic herbal formula Guizhi fuling wan for menopausal hot flushes: from experimental findings to clinical applications","volume":"7","author":"Li","year":"2019","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.015_bib41","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.7150\/ijms.55789","article-title":"Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jphs.2024.02.015_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580593","article-title":"Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jphs.2024.02.015_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2012.10.056","article-title":"Alkyl esters of gallic acid as anticancer agents: a review","volume":"60","author":"Locatelli","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.jphs.2024.02.015_bib44","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1021\/jf901308p","article-title":"Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung Xenograft tumor growth in vivo","volume":"57","author":"Ji","year":"2009","journal-title":"J Agric Food Chem"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.015_bib45","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/CAD.0000000000000565","article-title":"Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase\/p21\/p27 axis","volume":"28","author":"Lee","year":"2017","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.jphs.2024.02.015_bib46","series-title":"Association of Beta-Catenin, APC, SMAD3\/4, Tp53, and Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis","author":"Yan","year":"2022"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.015_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yexcr.2016.07.004","article-title":"NF-\u03baB-dependent transcriptional upregulation of cyclin D1 exerts cytoprotection against hypoxic injury upon EGFR activation","volume":"347","author":"Chen","year":"2016","journal-title":"Exp Cell Res"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.015_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1254\/jphs.13239FP","article-title":"Inhibition of smooth muscle cell proliferation by ezetimibe via the cyclin D1-MAPK pathway","volume":"125","author":"Qin","year":"2014","journal-title":"J Pharmacol Sci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:02:27Z","timestamp":1778594547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1347861324000264"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.02.015","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K\/AKT pathway and the down-regulation of cyclin D1 expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}